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Elucidation of several neglected reactions in
the GC–MS identiﬁcation of sialic acids as
heptaﬂuorobutyrates calls for an urgent
reassessment of previous claims†
Paola Rota,*a Luigi Anastasiab,c and Pietro Allevia
The current analytical protocol used for the GC–MS determination of free or 1,7-lactonized natural sialic
acids (Sias), as heptaﬂuorobutyrates, overlooks several transformations. Using authentic reference stan-
dards and by combining GC–MS and NMR analyses, ﬂaws in the analytical protocol were pinpointed and
elucidated, thus establishing the scope and limitations of the method. It was demonstrated that (a) Sias
1,7-lactones, even if present in biological samples, decompose under the acidic hydrolysis conditions
used for their release; (b) Sias 1,7-lactones are unpredicted artifacts, accidentally generated from their
parent acids; (c) the N-acetyl group is quantitatively exchanged with that of the derivatizing perﬂuorinated
anhydride; (d) the partial or complete failure of the Sias esteriﬁcation-step with diazomethane leads to the
incorrect quantiﬁcation and structure attribution of all free Sias. While these ﬁndings prompt an urgent
correction and improvement of the current analytical protocol, they could be instrumental for a critical
revision of many incorrect claims reported in the literature.
Introduction
N-Acetylneuraminic acid 1a (Neu5Ac), N-glycolylneuraminic
acid 2 (Neu5Gc), and 2-keto-3-deoxy-D-glycero-D-galacto-
nononic acid 3 (KDN) (Fig. 1) are the most representative
members of the sialic acid (Sias) family, a group of more than
sixty structurally distinct acidic monosaccharides that are
present in various natural glycoconjugates.1
Sias are usually linked to the non-reducing end of the
carbohydrate chain with an α-acetalic bond and are involved in
many key biological processes and pathologies, including
cancer and heart diseases.1,2
Because of the importance and diversity of Sias, eﬀorts
have been made to set-up suitable analytical methods for their
identification in biological samples of diﬀerent origin.1
The approach that more significantly contributed to ident-
ify and map the Sias family relies on the derivatization of their
hydroxyls as heptafluorobutyrates (HFBs) before GC–MS analy-
sis.1c,3 For instance, the application of this method recognized
about fifty diﬀerent sialic acids, more than fifteen of which are
new compounds, including the 1,7-lactones 4a–c of Neu5Ac
and the 1,7-lactone 5 of Neu5Gc as new members of the Sias
family (Fig. 1).1c,3b,g,h Owing to their stereochemistry, a surpris-
ing (yet unfortunately overlooked) feature of the allegedly
newly identified natural 1,7-lactones was that they could only
be linked to glycoconjugates with an unusual β-glycosidic
Fig. 1 Chemical structures of the most representative Sias and of the
corresponding 1,7-lactones.
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bond. Nonetheless, this did not raise any concern, and several
1,7-lactones of Neu5Ac were identified in biological samples
and reported to have crucial roles in a number of biological
processes and pathologies.3b,3i,4 For instance, 4a has been
described as a high-aﬃnity ligand for interleukin 4,4 and it was
found overexpressed in various cancer cells3i and in polycythe-
mia vera, a malignant disorder of hematopoietic stem cells.3b
The crucial steps for the identification of these 1,7-lactones
in glycoconjugates by GC–MS are acidic hydrolysis of their
acetalic bonds, followed by a derivatization reaction with
heptafluorobutyric anhydride (HFBAA), which is sometimes
preceded by diazomethane treatment.1c,3a,h The initial step
relies on the assumption that these 1,7-lactones are stable
under acidic conditions. However, during our previous studies
on Sias,5 we developed the synthesis of the free 1,7-lactones 4a
and 55g–i based on the ability of Neu5Ac 1a to form protected
1,7-lactones under acylation conditions,6 and observed their
low stability in protic solvents. This unfavorable feature
hindered their isolation and/or purification from aqueous
reaction mixtures,5g and posed some initial doubts about the
soundness of the analytical protocol currently used for their
identification.1c,3 Moreover, once we synthesized 4a in the pure
form and unequivocally assigned its structure by NMR, we sub-
jected it to HFBAA derivatization. Surprisingly, we recorded
diﬀerent mass spectra from the one previously reported,1c
which was obtained by subjecting a biological sample that
supposedly contained the same lactone 4a to the hydrolysis-
derivatization analytical protocol.1c,3
Altogether this evidence started to support the notion that
1,7-lactones 4a–c and other natural Sias could not be correctly
identified with the current analytical methodology.1c,3 While
this called for an extensive revision of the protocol, it also
prompted for an urgent in-depth reexamination of the behav-
ior of the 1,7-lactones 4a–c, of their parent acids 1a–c, and of
other analogs under the same reaction conditions used for
their identification. This step was mandatory in order to fix all
the incorrect claims reported in the literature,1c,3 which were
based on wrong structural assignments.
Results and discussion
Initially, we performed the synthesis of 4a5g–i and of its new
acetylated congeners 4b, c by adapting and expanding our pre-
vious synthetic protocol,5g–i using the lactone 7a as a key inter-
mediate as depicted in Scheme 1. In particular, we
accomplished the synthesis of the acetylated 1,7-lactones 4b–c
by elaboration of the intermediate lactone 7a, performing, in
the final step, the reductive regeneration of its acetal group,
under anhydrous conditions.
Then, we executed some hydrolytic stability tests on auth-
entic samples of compounds 4a–c. Lactones 4a, b5f were rather
unstable in aqueous solution, as they completely decomposed
within 24 hours at 23 °C by simply standing in D2O, as
revealed by NMR analyses. Only 4c survived for almost a week
when dissolved in water at 23 °C.
Moreover, as we anticipated, all of them decomposed under
the hydrolytic treatment (2 M aqueous acetic acid solution, at
80 °C for 90 min) used for their release from natural glyco-
conjugates.1c,3b,g,h The decomposition was complete for 4a and
4b and partial, but relevant (35%), for 4c. This evidence un-
ambiguously reveals that Neu5Ac 1,7-lactones 4a–c, even if
present in biological samples of glycoconjugates, cannot prop-
erly survive to the acidic hydrolysis required for their release.
Nonetheless, as they have been found by GC–MS in biological
samples after acidic hydrolysis, we speculated that they could
be unintentionally formed during the acylation of their parent
acids 1a–c with HFBAA. If that was the case, based on our
previous work on the N-transacylation of acetylamides,5d,5e
the protected 1,7-lactones formed during the derivatization
treatment with HFBAA (in CH3CN at 150 °C for 5 min), should
have the structure of the N-transacylated congeners 8a–c
(Scheme 2).
We verified this hypothesis by observing the reaction of
suitable amounts (15–30 mg scale) of the Sias 1a–c and of the
corresponding lactones 4a–c with HFBAA. Remarkably, under
the reported derivatization conditions, we obtained the same
protected N-transacylated 1,7-lactones 8a–c (Scheme 2). This
was evident from the GC–MS and NMR analyses of the crude
reaction products that clearly demonstrated the lack of any
acetamido group in the obtained compounds, which were in
fact completely acylated. However, we were surprised to
observe that their EI-MS fragmentation patterns (Fig. 2) were
diﬀerent from those reported for the alleged Neu5Ac 1,7-
lactones 4a–c.1c
In contrast, mass spectra were superimposable (for 8a, b) or
very similar (for 8c) to those reported for acids 1a–c, which
were analyzed as HFBs, after esterification with diazomethane,
according to the protocol.1c
In order to understand and clarify these discrepancies, we
first excluded that the 1,7-lactones resulting from an inner
Scheme 1 Syntheses of lactones 4a–c. Reagents and conditions: (i)
CbzCl, Et3N, THF-DMF, 0 °C → 23 °C, 30 min, 82%; (ii) (MeO)3CMe,
PPTS, THF, 23 °C, 1 h; (iii) H2, Pd/C, AcOEt, 25 °C, 3 h; (iv) Me2C(OMe)2,
p-TSA, DMF, 23 °C, 1 h; (v) Ac2O, Py, DMAP, 23 °C, 1 h; and (vi) moist
CF3COOH, CH2Cl2, 40 °C, 1 h.
Paper Organic & Biomolecular Chemistry
4932 | Org. Biomol. Chem., 2015, 13, 4931–4939 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
17
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
 S
tu
di
 d
i M
ila
no
 o
n 
26
/0
5/
20
15
 1
5:
19
:3
1.
 
View Article Online
lactonization of the allegedly formed methyl esters. To this
purpose, we subjected authentic and pure samples of Neu5Ac
1a–c methyl esters to the same GC–MS analysis as HFBs.
However, none of the obtained products (or byproducts)
showed an EI-MS profile similar to those we obtained for the
authentic 1,7-lactones 4a–c (Fig. 3).
Based on our data, we considered highly plausible that the
described1c,3 esterification step with diazomethane was either
partially or totally unsuccessful, and that the unreacted Sias
1a–c underwent an unforeseen lactonization in the successive
treatment with HFBAA. This forms the 1,7-lactones 8a–c, incor-
rectly identified in the reported experiments.1c,3 In fact,
neglecting both the unsuccessful esterification with diazo-
methane and the successive transesterification with HFBAA,
induced a massive misinterpretation of the GC–MS spectra,
resulting in extensive errors also in the identification
and quantification of free Sias present in the biological
samples.1c,3
Finally, in order to complete this intricate puzzle, we had to
establish the nature of the compounds responsible for the
mass spectral fragmentations erroneously attributed to the 1,7-
lactones 4a–c HFBs.1c,3b A conceivable explanation appeared to
be that they had the structure of untransacylated congeners of
8a–c, which are the unexpected byproducts of HFBAA treat-
ment. In fact, according to the mechanism of the N-transacyla-
tion of normal amides, treatment of the Sias 1a–c (or of the
lactones 4a–c) with HFBAA should initially form the lactonic
acetamides 9a–c (Scheme 3), which are in equilibrium with the
corresponding imides 10a–c in the sealed reaction vessel.5d
These imides, under the conditions described in the proto-
col (heating at 150 °C for 5 min), should irreversibly form the
Scheme 2 Syntheses of heptaﬂuorobutyric lactones 8a–c. Reagents
and conditions: (i) HFBAA, MeCN, 150 °C, 5 min.
Fig. 2 EI mass spectra of lactones 8a–c obtained by derivatization
(HFBAA, MeCN, 150 °C, 5 min) of the corresponding acids 1a–c or of the
lactones 4a–c (see ESI†).
Fig. 3 EI mass spectra obtained after derivatization (HFBAA, MeCN,
150 °C, 5 min) of the methyl esters of sialic acids 1a–c. A and B represent
the mass spectra of peaks at 7.80 and 8.84 min of the derivative of
methyl ester of 1a; C represent the mass spectrum of peak at 9.00 min
of the derivative of methyl ester of 1b; D represent the mass spectrum
of peak at 8.51 min of the derivative of methyl ester of 1c (see ESI†).
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N-transacylated amides 8a–c, in nearly quantitative yields. In
contrast, the imides 10a–c should at least partially survive
when the reaction is performed at lower temperatures and/or
for a shorter reaction time. During the work-up of the reaction
mixtures (evaporation of the solvent and of the HFBAA excess),
these imides should regenerate the untransacylated lactones
9a–c, in variable yields. If that was the case, variable amounts
of the acetamides 9a–c should be present in the final reaction
mixture, as a consequence of the equilibrium shift in favor of
the HFBs 9a–c. To test this hypothesis, we treated Neu5Ac 1a–c
and lactones 4a–c with HFBAA at lower temperature
(100–120 °C, for 5 min).1c As we expected, GC–MS analyses of
the reaction mixtures revealed that each N-transacylated
lactone 8a–c was accompanied by a second minor compound
showing a fragmentation pattern (Fig. 4) superimposable,
or very similar, to that of the reported HFBs of the 1,7-lactone
4a–c.1c
The assignment of the correct structures, 9a–c, to the
obtained by-products, which were erroneously considered
unesterified at the anomeric hydroxyl, was unequivocally con-
firmed by NMR analyses of authentic samples which were syn-
thesized on a 15–30 mg scale in reactions with HFBAA
performed at 23 °C.
Experimental
Materials and reagents
All chemicals and solvents used were of analytical grade and
purchased from Sigma-Aldrich (St. Louis, MO, USA). The sialic
acid 1a and its methyl ester were from Sigma-Aldrich. The
acetylated Sias 1b and 1c7 and the methyl ester of 1b8 were pre-
pared according to the indicated literature reports. The methyl
ester of acid 1c was obtained by treatment with diazomethane
of the parent acid as a white solid glass showing: elemental
analysis (Found: C, 47.2; H 6.15; N 3.5; C16H25NO11 requires
C, 47.2; H 6.2; N 3.4%); δH (CD3OD) 5.31 (1H, ddd, J4,3b 11.3,
J4,5 10.1, J4,3a 5.0, 4-H), 4.36 (1H, dd, J9a,9b 11.6, J9a,8 2.4, 9a-H),
4.17 (1H, dd, J6,5 10.6, J6,7 1.2, 1H, H-6), 4.15–4.08 (2H, overlap-
ping, 9b-H- and 5-H), 3.89 (1H, ddd, J8,7 9.1, J8,9b 6.3, J8,9a 2.4,
8-H), 3.78 (3H, s, COOCH3), 3.50 (1H, dd, J7,8 9.1, J7,6 1.2, 7-H),
2.30 (1H, dd, J3a,3b 12.7, J3a,4 5.0, 3a-H), 2.06 (3H, s, OCOCH3 at
C-9), 2.02 (3H, s, OCOCH3 at C-4), 1.97–1.93 (4H, overlapping,
3b-H and NHCOCH3); δc (CD3OD) 174.3, 173.1, 172.2, 171.4
(4C, NHCOCH3, OCOCH3 at C-4, OCOCH3 at C-9 and C-1), 96.5
(C-2), 71.7, 71.1, 70.2, 69.5 (C-4, C-6, C-7 and C-8), 67.8 (C-9),
53.3 (COOCH3), 51.2 (C-5), 37.7 (C-3), 22.6 (NHCOCH3), 20.9
and 20.8 (2C, OCOCH3 at C-4 and OCOCH3 at C-9); MS (ESI
positive) m/z 430.4 [M + Na]+.
The aqueous solutions of 2 M CH3COOD were taken from a
stock solution prepared by the addition of (CH3CO)2O (945 µL,
10.0 mmol) to cold D2O (8.0 mL) and dilution with D2O to
10.0 mL.
General remarks
Nuclear magnetic resonance spectra were recorded at 303 K on
a Bruker AM-500 spectrometer equipped with a 5 mm inverse-
geometry broadband probe and operating at 500.13 MHz for
1H and 125.76 MHz for 13C. Chemical shifts are reported in
parts per million (ppm, δ units) and are referenced for 1H
spectra, to a solvent residue proton signal (δ 7.26, 3.31, 2.50
and 1.94 ppm, respectively for CDCl3, CD3OD, (CD3)3SO and
CD3CN solutions) and for
13C spectra, to a solvent carbon
signal (central line at δ 77.0, 49.05, 39.43 and 1.24 ppm,
respectively for CDCl3, CD3OD, (CD3)3SO and CD3CN solu-
tions). The 1H and 13C resonances were assigned by 1H–1H
(COSY) and 1H–13C (HSQC and HMBC) correlation 2D experi-
ments. 1H NMR data are tabulated in the following order:
number of protons, multiplicity (s, singlet; d, doublet; br s,
broad singlet; m, multiplet), coupling constant(s) in hertz,
assignment of proton(s). GC–MS analysis was performed
by Finnigan TraceGC-ultra chromatograph coupled with a
Finnigan Trace DSQ mass spectrometer (Thermo Scientific,
Waltham, MA, USA). A capillary column (25 m × 0.25 mm i.d.)
with a HP-5MS bonded stationary phase film (0.25 µm thick-
ness, Agilent Technologies, USA) was used. The inlet tempera-
ture was maintained at 260 °C. The column oven was held at
100 °C for 1 min and then programmed from 100 to 270 °C at
20 °C min−1. The MS transfer line was set to 250 °C. Helium at
a constant flow-rate of 1 mL min−1 was used as a carrier gas.
The injection mode was split (split ratio, 50 : 1; split flow,
Fig. 4 EI mass spectra of lactones 9a–c obtained by derivatization with
HFBAA at 23 °C of the acids 1a–c and of the lactones 4a–c (see ESI†).
Scheme 3 Formation and N-transacylation of lactones 8a–c. Reagents
and conditions: (i) HFBAA excess, MeCN, 150 °C, 5 min.
Paper Organic & Biomolecular Chemistry
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50 mL min−1) and the injection volume was 1 µL. The analyses
were performed in the EI mode (ionization energy 70 eV;
source temperature 200 °C). Optical rotations were performed
on a polarimeter equipped with a 1 dm tube; [α]D values are
given in 10−1 deg cm2 g−1 and the concentrations are given in
g per 100 mL. ESI mass spectra were recorded using a Finnigan
LCQdeca quadrupole ion trap mass spectrometer (Finningan
Thermo Quest, San Jose, CA, USA) equipped with an electro-
spray ion (ESI) source and the spectra were collected in con-
tinuous flow mode by connecting the infusion pump directly
to the ESI source. The reactions were monitored, when poss-
ible, by thin-layer chromatography (TLC) carried out on
0.25 mm E. Merck silica gel plates (60 F254) using UV light,
50% sulphuric acid or 0.2% ninhydrin in ethanol and heat as
the developing agent. E. Merck 230–400 mesh silica gel was
used for flash column chromatography.
Preparation of 2-benzyloxycarbonyl-N-acetylneuraminic acid
1,7-lactone 7a
Sialic acid 1a (900 mg, 2.91 mmol), dissolved in DMF (10 mL)
at 60 °C, under stirring, was cooled at 0 °C and diluted with
THF (8 mL). Then CbzCl (1.04 mL; 7.28 mmol, 2.5 eq.) in THF
(4 mL) was added in a single portion, followed by Et3N
(1.20 mL; 8.73 mmol, in a single addition). The mixture was
then stirred for 30 min at 23 °C. After this, methanol (2 mL)
was added dropwise and the stirring was continued for
15 min. Evaporation of the solvent under reduced pressure
(22 mmHg and then at 10−1 mmHg) aﬀorded a crude residue,
which, after purification by flash chromatography (eluting
with AcOEt–MeOH, 9 : 1, v : v), aﬀorded the pure Neu5Ac 1,7-
lactone 6 (1.01 g; 82%) as a white solid: mp 122–124 °C. The
other physico-chemical properties are identical to those
reported. This procedure uses a reduced amount of benzyloxy-
carbonyl chloride (CbzCl) in the synthesis of the 1,7-lactones
to address issues relating to the required excess of CbzCl.5i
Preparation of 9-O-acetyl-N-acetylneuraminic acid 1,7-
lactone 4b
Synthesis of 9-O-acetyl-2-benzyloxycarbonyl-N-acetylneurami-
nic acid 1,7-lactone (7b). Trimethyl orthoacetate (110 µL) and
pyridinium p-toluenesulfonate (10 mg) were added in a
sequence to a solution of the 2-benzyloxycarbonyl 1,7-lactone
7a (200 mg, 0.480 mmol) dissolved in tetrahydrofuran (5 mL)
and the solution was stirred at 25 °C for 1 h. Then water
(0.2 mL) was added and the solution stirred for 30 min before
neutralization with a weak basic resin (IRA-67), filtered and
the solvent evaporated under reduced pressure to aﬀord a
crude residue. The residue was purified by column chromato-
graphy on silica gel (eluting with AcOEt–MeOH, 95 : 5, v/v), to
aﬀord the pure 9-O-acetyl-2-benzyloxycarbonyl-N-acetylneura-
minic acid 1,7-lactone 7b (182 mg, 85%) as a glass: [α]20D + 13.1
(c 1 in MeOH); elemental analysis (Found: C, 53.9; H, 5.4; N,
2.95; C21H25NO11 requires C, 54.0; H, 5.4; N, 3.0%); δH
(CD3OD) 7.43–7.40 (5H, overlapping, Ph), 5.24–5.16 (2H, AB
system, CH2Ph), 4.63 (1H, br s, 6-H), 4.46 (1H, d, J7,8 9.1, 7-H),
4.41 (dd, J9a,9b 11.6, J9a,8 1.7, 1H, 9a-H), 4.24 (1H, dd, J9b,9a
11.6, J9b,8 4.7, 9b-H), 4.19–4.14 (1H, 1H, 8-H), 4.12–4.09 (1H, br
s, 4-H), 4.65–4.35 (1H, br s, H-5), 2.29 (1H, dd, J3a,3b 13.9, J3a,4
3.1, 3a-H), 2.11 (1H, br d, J3a,3b 13.9, 3b-H), 2.11 (3H, s,
OCOCH3 at C-9), 2.01 ppm (3H, s, NHCOCH3); δc (CD3OD)
172.9 (2C, NHCOCH3 and OCOCH3 at C-9), 167.6 (C-1), 153.5
(PhCH2OCOO), 136.3, 129.8, 129.7, 129.4 (Ph), 94.9 (C-2), 80.0
(C-7), 73.2 (C-6), 71.4 (PhCH2OCOO), 69.6 (C-8), 67.4 (C-4), 66.2
(C-9), 52.5 (C-5), 37.0 (C-3), 22.5 (NHCOCH3), 20.8 (OCOCH3 at
C-9); MS (ESI positive) m/z 490.1 [M + Na]+.
Synthesis of 9-O-acetyl-N-acetylneuraminic acid 1,7-lactone
(4b). The 1,7-lactone 7b (300 mg, 0.64 mmol) was dissolved in
ethyl acetate (65 mL) and hydrogenated in the presence of 10%
Pd/C (30 mg) for 3 h. Then the catalyst was filtered on a pad of
Celite and washed with anhydrous THF. The removal of the
solvent, under reduced pressure, aﬀorded the 9-O-acetyl-N-
acetylneuraminic acid 1,7-lactone 4b (200 mg, 95%) as an
amorphous white solid that completely decomposes on stand-
ing at room temperature for one month and shows: [α]20D + 13.1
(c 1 in THF); elemental analysis (Found: C, 46.8; H, 5.8; N, 4.1;
C13H19NO9 requires C, 46.85; H, 5.75; N, 4.2%); δH (DMSO-d6):
8.24 (1H, d, JNH,5 7.9, NHCOCH3), 7.35 (1H, s, OH at C-2), 5.63
(1H, d, JOH,8 6.6, OH at C-8), 5.47 (1H, d, JOH,4 2.3, OH at C-4),
4.35–4.27 (2H, overlapping, 6-H and 9a-H), 4.20 (1H, d, J7,8
8.9 Hz, 7-H), 3.95 (1H, dd, J9b,9a 11.6, J9b,8 5.9, 9b-H), 3.81 (1H,
br s, 4-H), 3.80–3.72 (2H, overlapping, 8-H and 5-H), 2.04 (3H,
s, OCOCH3), 1.97 (1H, dd, J3a,3b 13.8, J3a,4 2.9, 3a-H), 1.87 (3H,
s, NHCOCH3), 1.81 (1H, br d, J3b,3a 13.8, 3b-H); δc (DMSO-d6)
170.3 (1C, OCOCH3), 169.0 (C-1), 168.9 (NHCOCH3), 90.4 (C-2),
77.7 (C-7), 70.1 (C-8), 68.4 (C-6), 65.9 (C-4), 64.8 (C-9), 50.2
(C-5), 30.3 (C-3), 22.3 (NHCOCH3), 20.7 (OCOCH3); MS (ESI
negative) m/z 332.6 [M − H]−.
Preparation of 4,9-O-diacetyl-N-acetylneuraminic acid
1,7-lactone 4c
Synthesis of 8,9-isopropylidene-2-benzyloxycarbonyl-N-acetyl-
neuraminic acid 1,7-lactone (7c). To a solution of 2-benzyloxy-
carbonyl N-acetylneuraminic acid 1,7-lactone 7a (200 mg,
0.480 mmol) in DMF (2.0 mL), 2,2-dimethoxypropane (580 µL,
4.8 mmol) was added followed by p-toluenesulfonic acid
(2 mg). The mixture was stirred at 23 °C for 1 h and then was
neutralized with a weak basic resin (IRA-67) and filtered. The
solvent was then evaporated, under reduced pressure, and the
residue was chromatographed on silica gel (eluting with
AcOEt–hexane, 95 : 5, v/v) to aﬀord the 1,7-lactone 7c (174 mg,
81%) as a glass; [α]20D 19.2 (c 1 in MeOH); elemental analysis
(Found: C, 56.8; H, 5.9; N, 3.1; C22H27NO10 requires C, 56.8; H,
5.85; N, 3.0%); δH (CD3OD) 7.40–7.32 (5H, overlapping, Ph),
5.20–5.15 (2H, AB system, CH2Ph), 4.49 (1H, br s, 6-H), 4.43
(1H, ddd, J8,7 9.4, J8,9b 5.7, J8,9a 4.2, 8-H), 4.30 (1H, d, J7,8 9.4,
7-H), 4.16–4.06 (3H, overlapping, 9a-H, 9b-H and 4-H), 4.01–
3.99 (1H, br s, 5-H), 2.27 (1H, dd, J3a,3b 13.9, J3a,4 3.4, 3a-H),
2.11 (1H, d, J3a,3b 13.9, 3a-H), 1.99 (3H, s, NHCOCH3), 1.40
(1H, s, C(CH3)2), 1.34 (1H, s, C(CH3)2); δc (CD3OD) 172.9 (1C,
NHCOCH3), 167.5 (C-1), 153.5 (PhCH2OCOO), 136.3, 129.8,
129.7, 129.4 (Ph), 111.2 (1C, C(CH3)2), 94.9 (C-2), 80.7 (C-7),
75.6 (C-6), 73.6 (PhCH2OCOO), 71.4 (C-8), 67.8 (C-4), 67.3 (C-9),
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52.4 (C-5), 37.0 (C-3), 27.4 (1C, C(CH3)2), 25.5 (1C, C(CH3)2),
22.4 (NHCOCH3); MS (ESI positive) m/z 488.1 [M + Na]
+.
Synthesis of 8,9-isopropylidene-4-acetyl-2-benzyloxycarbonyl-
N-acetylneuraminic acid 1,7-lactone (7d). Protected 1,7-lactone
7c (240 mg, 0.516 mmol), dissolved in pyridine (0.6 mL), was
treated with acetic anhydride (150 µL, 1.50 mmol) containing
a trace of 4-dimethylamino pyridine. After 1 h at 23 °C, a
methanol solution was added and concentrated under reduced
pressure. Ice cold water was added to the crude residue and
extracted with ethyl acetate. After drying with anhydrous
sodium sulfate, the organic layer was filtered and the solvent
evaporated under reduce pressure to aﬀord a crude residue
that was chromatographed on silica gel (eluting with AcOEt–
hexane, 95 : 5, v/v) to aﬀord the compound 7d (230 mg, 87%)
as a glass; [α]20D + 14.2 (c 1 in MeOH); elemental analysis
(Found: C, 56.7; H, 5.8; N, 2.7; C24H29NO11 requires C, 56.8; H,
5.8; N, 2.8%); δH (CDCl3) 7.39–7.30 (5H, overlapping, Ph), 6.30
(1H, d, JNH,5 8.2, NHCOCH3), 5.20–5.14 (2H, AB system,
CH2Ph), 5.08 (1H, br s, 1H, 4-H), 4.55 (1H, s, 6-H), 4.51 (1H,
ddd, J8,7 9.7, J8,9b 5.4, J8,9a 4.0, 8-H), 4.22–4.14 (4H, overlap-
ping, 9a-H, 9b-H, 7-H and 5-H), 2.36 (1H, br d, J3a,3b 14.9,
3a-H), 2.16 (1H, dd, J3a,3b 13.9, J3b,4 3.7, 3a-H), 2.04 (3H, s,
OCOCH3 at C-4), 2.01 (3H, s, NHCOCH3), 1.42 (1H, s, C(CH3)2),
1.35 (1H, s, C(CH3)2; δc (CD3OD) 169.4 (1C, OCOCH3 at C-4),
169.0 (1C, NHCOCH3), 164.4 (C-1), 151.7 (PhCH2OCOO), 134.0,
128.9, 128.7, 128.3 (Ph), 110.2 (1C, C(CH3)2), 93.1 (C-2), 79.2
(C-7), 73.6 (C-6), 72.3 (PhCH2OCOO), 70.7 (C-8), 67.5 (C-4), 66.8
(C-9), 48.3 (C-5), 33.2 (C-3), 27.1 C(CH3)2, 25.0 C(CH3)2, 23.0
(NHCOCH3), 20.7 (OCOCH3 at C-4); MS (ESI positive) m/z 530.4
[M + Na]+.
Synthesis of 4,9-diacetyl 2-benzyloxycarbonyl-N-acetylneur-
aminic acid 1,7-lactone (7e). To a solution of 1,7-lactone 7d
(100 mg, 0.200 mmol) in dichloromethane (1.5 mL) moist TFA
(0.4 µL) was added and the solution was refluxed for 1 h.
Then, a weak basic resin (IRA-67) was added to the mixture
that was filtered and the solvent evaporated under reduced
pressure to give a crude glass that was then purified by column
chromatography on silica gel (eluting with AcOEt–hexane,
from 95 : 1 then 90 : 10, v/v), to aﬀord pure 4-O-acetyl-2-benzy-
loxycarbonyl-N-acetylneuraminic acid 1,7-lactone (87 mg, 85%)
as a glass; [α]20D + 17.2 (c 1 in MeOH); elemental analysis
(Found: C, 53.9; H, 5.3; N, 3.1; C21H25NO11 requires C, 54.0; H,
5.4; N, 3.0%); δH (CD3OD) 7.40–7.31 (5H, overlapping, Ph),
5.25–5.14 (2H, AB system, CH2Ph), 5.06 (1H, br s, 4-H), 4.74 (s,
1H; 6-H), 4.51 (1H, d, J7,8 9.3, 7-H), 4.14–4.10 (1H, br m, 5-H),
4.04 (1H, ddd, J8,7 9.3, J8,9b 4.0, J8,9a 2.9, 8-H), 3.86–3.75 (2H,
overlapping, 9a-H and 9b-H), 2.40 (1H, dd, J3a,3b 14.6, J3a,4 3.8,
1H; 3a-H), 2.28 (1H, br d, J3b,3a 14.6, 1H, 3b-H), 2.05 (3H, s,
OCOCH3 at C-4), 2.03 (3H, s, NHCOCH3); δc (CD3OD) 172.9
(1C, OCOCH3 at C-4), 170.7 (1C, NHCOCH3), 167.3 (C-1), 153.5
(PhCH2OCOO), 136.2, 129.8, 129.7, 129.3 (Ph), 94. 7 (C-2), 80.0
(C-7), 73.4 (C-6), 71.6 (PhCH2OCOO), 71.5 (C-8), 69.5 (C-4), 63.2
(C-9), 50.2 (C-5), 34.3 (C-3), 22.4 (NHCOCH3), 20.7 (OCOCH3 at
C-4); MS (ESI positive) m/z 490.5 [M + Na]+, 957.0 [2M + Na]+.
The obtained 8,9-unprotected lactone (80 mg, 0.172 mmol) in
THF (2.0 mL) was treated with trimethyl orthoacetate (66 µL)
containing a catalytic amount of pyridinium p-toluenesulfo-
nate (5 mg), for 1 h at 23 °C. At this time, water (0.2 mL) was
added, and the mixture stirred for 30 min at room tempera-
ture, and then neutralized with a weak basic resin (IRA-67), fil-
tered and evaporated. The residue was chromatographed on
silica gel (eluting with AcOEt–MeOH, from 98 : 2 to 95 : 5, v/v),
to aﬀord the title compound 7e (64 mg, 77%) as a glass: [α]20D +
14.1 (c 1 in MeOH); elemental analysis (Found: C, 54.14; H,
5.4; N, 2.7; C23H27NO12 requires C, 54.2; H, 5.3; N, 2.75%); δH
(CD3OD) 7.40–7.31 (5H, overlapping, Ph), 5.23–5.14 (2H, AB
system, CH2Ph), 5.07 (1H, br s, 4-H), 4.70 (1H, s, 6-H), 4.48
(1H, d, J7,8 9.1, 7-H), 4.53–4.48 (1H, m, 8-H), 4.29–4.19 (2H,
overlapping, 9a-H and 9b-H), 4.21 (1H, br s, 5-H), 2.39 (1H, dd,
J3a,3b 14.7, J3a,4 3.8, 3a-H), 2.25 (1H, br d, J3a,3b 14.7, 3b-H), 2.10
(3H, s, OCOCH3 at C-9), 2.02 (3H, s, OCOCH3 at C-4), 2.00 (3H,
s, NHCOCH3); δc (CD3OD): 172.9, 172.8, 170.6 (3C, OCOCH3 at
C-9, OCOCH3 at C-4 and NHCOCH3), 166.9 (C-1), 153.4
(PhCH2OCOO), 136.1, 129.8, 129.7, 129.4 (Ph), 94.7 (C-2), 80.4
(C-7), 73.3 (C-6), 71.6 (PhCH2OCOO), 69.4 (C-8), 69.2 (C-4), 66.2
(C-9), 50.0 (C-5), 34.2 (C-3), 22.4 (NHCOCH3), 20.8 and 20.7
(2C, OCOCH3 at C-4 and OCOCH3 at C-9); MS (ESI positive) m/z
532.3 [M + Na]+, 1041.8 [2M + Na]+.
Synthesis of 4,9-O-diacetylated N-acetylneuraminic acid 1,7-
lactone (4c). The 2-protected 1,7-lactone 7e (60 mg,
0.120 mmol) was dissolved in ethyl acetate (13 mL) and hydro-
genated in the presence of 10% Pd/C (6 mg) for 3 h. The cata-
lyst was then filtered on a pad of Celite that was washed with
anhydrous THF. The obtained solution was evaporated under
reduced pressure to aﬀord the title compound 4c (36 mg, 81%)
as an amorphous solid: [α]20D + 11.2 (c 1 in THF); elemental
analysis (Found: C, 48.1; H, 5.6; N, 3.8; C15H21NO10 requires C,
48.1; H, 5.6; N, 3.7%); δH (DMSO-d6) 8.44 (1H, d, JNH,5 7.7, 1H,
NHCOCH3), 7.61 (1H, s, OH at C-2), 5.67 (1H, d, JOH,8 = 6.3, OH
at C-8), 4.85 (1H, br s, H-4), 4.41 (1H, s, 6-H), 4.31 (1H, dd,
J9a,9b 11.6, J9a,8 4.2, 1H, 9a-H), 4.28 (1H, d, J7,8 8.9, H-7), 4.20
(1H, dd, J9b,9a 11.6, J8,9a 6.1, 9a-H), 3.89–3.80 (2H, overlapping,
8-H and 5-H), 2.15 (1H, dd, J3a,3b 14.8, J3b,4 3.7, 3a-H), 2.05
(3H, s, OCOCH3), 1.94 (3H, s, OCOCH3), 1.89 (4H, overlapping,
3b-H and NHCOCH3); δc (DMSO-d6) 170.3, 169.1 (2C, OCOCH3
at C-4 and OCOCH3 at C-9), 168.8 (C-1), 168.6 (NHCOCH3),
90.4 (C-2), 78.2 (C-7), 70.1 (C-8), 68.5 (C-6), 68.2 (C-4), 65.0
(C-9), 47.7 (C-5), 30.3 (C-3), 22.3 (NHCOCH3), 20.6, 20.5 (2C,
OCOCH3 at C-4 and OCOCH3 at C-9); MS (ESI negative) m/z
374.4 [M − H]−.
Stability tests of lactones 4a–c under neutral and acidic
conditions
Tests under aqueous neutral conditions. General procedure.
Each pure lactone 4a–c (20 mg) was dissolved with D2O
(0.7 mL) in a NMR tube at 23 °C and its proton spectrum was
acquired at diﬀerent times: immediately, after 15 min, and
after 24 h.
The lactones 4a and 4b showed a very poor stability
showing, also in the first acquired spectrum, the partial dis-
appearance of the characteristic peaks observed for these lac-
tones in (CD3)2SO. In all cases the starting lactone appears to
Paper Organic & Biomolecular Chemistry
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be completely absent after 24 h without any documentable
presence of the parent acids 1a and 1b.
Lactone 4c showed greater stability in water, in fact its spec-
trum appeared unchanged after 24 h in D2O.
Tests under aqueous acidic conditions (2 M aq. acetic acid).
General procedure. Each 1,7-lactone 4a–c (20 mg) was dis-
solved at 23 °C in CH3COOD (2 M in D2O) obtained by dissol-
ving anhydrous Ac2O in D2O (see the Materials and reagents
section) and the test tube was sealed. The solution was heated
at 80 °C for 105 min. At this time, each crude reaction mixture
was subjected to the 1H-NMR analyses.
All signals corresponding to 1,7-lactones 4a and 4b comple-
tely disappeared. In the case of the lactone 4a, some character-
istic signals documented the presence of trace amounts of the
parent sialic acid 1a in the reaction mixture. In contrast, no
indication of the presence of the parent acid 1b could be
obtained in the reaction of the lactone 4b.
The 1,7-lactone 4c partially survived (around 65%) the
acidic hydrolysis and was accompanied by the parent acid 1c
in the final reaction mixture.
Synthesis and characterization of HFB derivatives 8a–c from
the free parent acids 1a–c and from the 1,7-lactones 4a–c
General procedure. The appropriate acid or 1,7-lactone
(0.05 mmol), dissolved in CH3CN (0.7 mL), was treated with
HFBAA (245 µL, 1.0 mmol) at 150 °C for 5 min. An aliquot of
the crude mixture was diluted with CH3CN and directly sub-
jected to GC–MS analyses. Then, the remaining reaction
mixture was evaporated under a stream of nitrogen and the
crude residue was dissolved in CDCl3 for the NMR analyses.
Starting from acid 1a and from lactone 4a. The crude reac-
tion mixtures obtained starting from the acid 1a and from the
lactone 4a showed superimposable 1H- and 13C-NMR spectra,
identical to that of the compound of structure 8a reported in
the literature5f and in GC–MS analysis, both showed a single
peak with the same retention time (tR 6.61 min) and mass
spectrum (Fig. 2).
Starting from acid 1b and from lactone 4b. The crude
residue obtained in the reactions of the acid 1b and of the
lactone 4b showed superimposable 1H-NMR spectra, identical
to that we reported5f for the compound of structure 8b and
13C-NMR spectrum δc (CDCl3) 173.0 (1C, OCOCH3 at C-9),
160.9 (C-1), 93.2 (C-2), 76.0 (C-7), 74.4 (C-8), 71.4 (C-6), 70.1
(C-4), 61.1 (C-9), 48.7 (C-5), 32.5 (C-3), 20.1 (1C, OCOCH3 at
C-9). The GC–MS analyses of crude products obtained from
compounds 1b and 4b showed, in both cases, a single peak
with the same retention time (tR 7.24 min) and identical mass
spectrum (Fig. 2).
Starting from acid 1c and from lactone 4c. The crude resi-
dues obtained in the reaction of the acid 1c and the lactone 4c
showed superimposable 1H- and 13C-NMR spectra that were in
agreement with the structure of the 1,7-lactone 8c: δH (CDCl3):
7.36–7.30 (1H, m, NHCOCH3), 5.69–5.66 (1H, m, 8-H), 5.51
(1H, br s, 4-H), 4.95–4.88 (2H, overlapping, 7-H and 9a-H),
4.48–4.41 (3H, overlapping, 5-H, 6-H and 9b-H), 2.55 (1H, br d,
J3a,3b 14.6, 3a-H), 2.41 (1H, dd, J3b,3a 14.6, J3b,4 2.5, 3b-H), 2.18
(3H, s, OCOCH3 at C-9), 2.13 (3H, s, OCOCH3 at C-4); δc
(CDCl3) 172.8 and 169.7 (2C, OCOCH3 at C-4 and OCOCH3 at
C-9), 161.8 (C-1), 93.9 (C-2), 76.2 (C-7), 74.4 (C-8), 71.8 (C-6),
66.6 (C-4), 61.2 (C-9), 49.0 (C-5), 32.8 (C-3), 20.4 and 20.3 (2C,
OCOCH3 at C-4 and OCOCH3 at C-9). Their GC–MS analysis
showed in both cases a single peak with the same retention
time (tR 8.30 min) and mass spectrum (Fig. 2).
Inspection by GC–MS analysis of analytical amount of acids
1a–c, lactones 4a–c and methyl esters of acids 1a–c, after
derivatization with HFBAA
General procedure. The derivatization was performed adopt-
ing the protocol reported by Zanetta et al.1c,3b avoiding the
sometimes reported treatment with diazomethane.1c,3b In sep-
arate experiments, samples of the compounds (0.1–1 µg) were
dissolved in CH3CN (200 µL) with the addition of HFBAA
(25 µL). The vessels were then closed and heated at 150 °C for
5 min. After cooling, the solvent was stripped under a stream
of nitrogen. The residue was then dissolved in anhydrous
CH3CN and injected for GC–MS analysis.
Starting from Sias 1a–c and their lactones 4a–c. The acids
1a–c and their 1,7-lactones 4a–c aﬀorded chromatographic pro-
files and mass spectra identical to those described above for
the 1,7-lactones 8a–c.
Starting from methyl ester of sialic acid 1a. Authentic
methyl ester of the acid 1a aﬀorded a reaction product respon-
sible for two chromatographic peaks (at tR 7.80 min and tR
8.84 min respectively) associated with mass spectral fragmen-
tations (A and B, Fig. 3) that completely diﬀer from that
reported by Zanetta for sialic acid 1a, after methylation with
diazomethane and perfluoracylation.1c They also diﬀer from
that of the lactone 8a that we obtained starting with the
lactone 4a or with the acid 1a.
Starting from methyl ester of sialic acid 1b. Authentic
methyl ester of the acid 1b aﬀorded a single chromatographic
peak (tR 9.00 min) associated with a mass spectrum (C, Fig. 3)
completely diﬀerent from that reported by Zanetta for the
same acid, after methylation with diazomethane and perfluor-
acylation.3 It also diﬀers from that we assigned to the lactone
8b, starting from the lactone 4b or from the acid 1b.
Starting from methyl ester of sialic acid 1c. Authentic
methyl ester of the acid 1c aﬀorded a single chromatographic
peak (tR 8.51 min) associated with a mass spectrum (D, Fig. 3)
that completely diﬀers from that attributed by Zanetta to acid
1c after methylation with diazomethane and perfluoracyla-
tion.1c It was also diﬀerent from that we assigned to the
lactone 8c obtained for the lactone 4c or from the acid 1c.
Preparation of the untransacylated derivatives 9a–c by
derivatization of the lactones 4a–c and of the acids 1a–c
General procedure. Each acid or 1,7-lactone (0.05 mmol)
was dissolved in CH3CN (0.7 mL) and treated with HFBAA
(245 µL; 1.0 mmol) at 23 °C for 3 h. Then, each reaction
mixture was evaporated under a stream of nitrogen and two
samples of the crude residue were dissolved in CDCl3 for the
NMR analyses, and in CH3CN for the GC–MS analyses. Parallel
Organic & Biomolecular Chemistry Paper
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reactions of the lactones 4a–c and the acids 1a–c were also
performed at 120 °C for 5 min. After the work-up, the crude
reaction mixtures were subjected exclusively to GC–MS
analyses.
Preparation of the lactone 9a. Derivatization treatment of
the lactone 4a at 23 °C aﬀorded the lactone 9a, as a crude
product that decomposes in any purification attempt. It
showed: δH (CDCl3) 6.60 (1H, d, JNH,5 7.9, NH), 5.68 (1H, ddd,
J8,7 8.3, J8,9b 3.8, J8,9a 2.1, 8-H), 5.49 (1H, br s, 4-H), 4.99 (1H,
dd, J9a,9b 13.0, J9a,8 2.1, 9a-H), 4.86 (1H, d, J8,7 8.3, 7-H), 4.76
(1H, dd, J9b,9a 13.0, J9b,8 3.8, 9b-H), 4.51 (1H, br d, J5,NH 7.9,
5-H), 4.38 (1H, br s, 6-H), 2.59 (1H, dd, J3a,3b 15.4, J3b,4 2.0,
3a-H), 2.54 (1H, dd, J3b,3a 15.4, J3b,4 3.9, 3b-H) 2.19 (3H, s,
NHCOCH3); δc (CDCl3) 173.0 (1C, NHCOCH3), 160.5 (C-1), 93.4
(C-2), 75.2 (C-7), 73.2 (C-8), 72.1 (C-6), 70.4 (C-4), 63.5 (C-9),
48.1 (C-5), 32.5 (C-3, 22.5 (NHCOCH3).
Its GC–MS analysis showed a single chromatographic peak
(tR 7.47 min) associated with the mass spectrum reported in
the figure (Fig. 4). The EI spectrum of the lactone 9a was iden-
tical in all respects to that erroneously attributed by Zanetta
et al.1c to the congener unesterified at the anomeric hydroxyl.
Performing the derivatization of the lactone 4a and of the
acid 1a, at 120° for 5 min, we obtained, in both cases, a reac-
tion product responsible for two peaks in GC–MS analysis. We
identified the major compound as the lactone 8a, and the
minor one as the lactone 9a.
Preparation of the lactone 9b. Derivatization treatment of
lactone 4b aﬀorded a product, identified as the crude lactone
9b, unstable to any attempted purification. It showed: δH
(CDCl3) 7.04 (d, JNH,5 7.6 Hz, NH), 5.58 (1H, ddd, J8,7 6.6, J8,9b
5.9, J8,9a 2.0, 8-H), 5.54 (1H, br s, 4-H), 4.99 (1H, dd, J9a,9b 13.2,
J9a,8 2.0, 9a-H), 4.86 (1H, d, J8,7 6.6, H-7), 4.52–4.45 (2H, over-
lapping, 5-H and 6-H), 4.41 (1H, dd, J9b,9a 13.2, J9b,8 5.9, 9b-H),
2.60–2.51 (2H, overlapping, 3a-H and 3b-H), 2.18 (3H, s,
OCOCH3 at C-9), 2.14 (3H, s, NHCOCH3); δc (CDCl3) 173.7 (1C,
OCOCH3 at C-9), 173.6 (1C, NHCOCH3), 161.4 (C-1), 93.3 (C-2),
76.2 (C-7), 75.0 (C-8), 71.8 (C-6), 70.6 (C-4), 61.5 (C-9), 48.3
(C-5), 32.3 (C-3), 22.2 (NHCOCH3), 20.2 (1C, OCOCH3 at C-9).
Its GC–MS analysis showed a single chromatographic peak
(tR 8.55 min) associated with the mass spectrum reported in
the figure (Fig. 4). The mass spectrum of the lactone 9b was
identical in all respects to that erroneously attributed by
Zanetta et al.1c to the congener unesterified at the anomeric
hydroxyl.
Performing the derivatization of the lactone 4b and of the
acid 1b, at 120° for 5 min, we obtained, in both cases, a reac-
tion product responsible for two peaks in GC–MS analysis. We
identified the major compound as the lactone 8b, and the
minor one as the lactone 9b.
Preparation of the lactone 9c. Derivatization treatment of
lactone 4c aﬀorded a product, identified as the lactone 9c,
unstable to any attempted purification, showing: δH (CDCl3)
6.92 (1H, d, JNH,5 7.9, NH), 5.62 (1H, ddd, J8,7 8.5, J8,9b 6.3, J8,9a
2.2, 8-H), 5.30–5.26 (1H, br s, 4-H), 4.92–4.86 (2H, overlapping,
7-H and 9a-H), 4.45 (1H, br s, 6-H), 4.42–4.36 (2H, overlapping,
5-H and 9b-H), 2.49 (1H, br d, J3a,3b 15.0, 3a-H), 2.37 (1H, dd,
J3b,3a 15.0, J3b,4 3.7, 1H, 3b-H), 2.19 (3H, s, COCH3), 2.18 (3H, s,
COCH3), 2.12 (3H, s, NHCOCH3); δc (CDCl3) 173.4 and 170.3
(3C, OCOCH3 at C-4, OCOCH3 at C-9 and NHCOCH3), 162.3
(C-1), 94.0 (C-2), 76.5 (C-7), 74.9 (C-8), 72.1 (C-6), 67.2 (C-4),
61.6 (C-9), 48.7 (C-5), 32.6 (C-3), 22.1 (NHCOCH3), 20.4 (2C,
COCH3 at C-9 and COCH3 at C-4).
Its GC–MS analysis showed a single chromatographic peak
(tR 9.74 min) associated with the mass spectrum reported in
the figure (Fig. 4). The mass spectrum of the lactone 9c was
identical in all respects to that erroneously attributed by
Zanetta et al.1c to the congener unesterified at the anomeric
hydroxyl.
Performing the derivatization of the lactone 4c and of the
acid 1c, at 120° for 5 min, we obtained, in both cases, a
reaction product responsible for two peaks in GC–MS analysis.
We identified the major component of the mixture as the
lactone 8c, and the minor one as the lactone 9c.
Conclusions
This work demonstrates that the current analytical protocol1c,3
for the GC–MS identification of natural Sias and of their 1,7-
lactones as HFBs in glycoconjugates has numerous critical
flaws. Unfortunately, neglecting several reactions encouraged
the misinterpretation of many crucial MS spectra. This caused
a detrimental domino eﬀect,1b as many claims in the literature
rely on the incorrect identification of Sias with this analytical
method.1c For instance we established that 1,7-lactones 4a–c,
although they had been identified with this methodology and
reported to have important biological roles also in patholo-
gies,3b,3i,4 could not be determined with this approach,
because they are decomposed during the hydrolysis step. In
fact, those detected 1,7-lactones are merely artifacts formed by
lactonization of the corresponding acids, under the acylation
conditions used for their derivatization. The acylation with
HFBAA also causes a second neglected reaction which
exchanges the N-acetyl group (present in all Sias of the Neu5Ac
family) with that of the derivatizing perfluorurated anhydride,
to aﬀord diﬀerent derivatives from those predicted and
reported. Neglecting this transformation and overlooking the
unexpected failure of the esterification step with diazomethane
also caused extensive errors in the identification and quantifi-
cation of free Sias. While we feel that an urgent correction and
improvement of the present analytical protocol1c,3 is manda-
tory, we are assured that the extensive data herein reported will
allow a critical revision of the literature in this field.
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